TransCode Therapeutics - 53 Year Dividend History | RNAZ
Historical dividend payout and yield for TransCode Therapeutics (RNAZ) since 1971. The current TTM dividend payout for TransCode Therapeutics (RNAZ) as of December 20, 2024 is $0.00. The current dividend yield for TransCode Therapeutics as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.003B |
$0.000B |
|
TransCode Therapeutics is an emerging RNA oncology company. Its platform of investigational drug candidates is dedicated to improving patient outcomes encompassing a variety of tumor types. The company's lead therapeutic candidate includes TTX-MC138. TransCode Therapeutics is based in BOSTON.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
